BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 27539597)

  • 1. The Benefits of Exercise and Metabolic Interventions for the Prevention and Early Treatment of Alzheimer's Disease.
    Maliszewska-Cyna E; Lynch M; Oore JJ; Nagy PM; Aubert I
    Curr Alzheimer Res; 2017; 14(1):47-60. PubMed ID: 27539597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple effects of physical activity on molecular and cognitive signs of brain aging: can exercise slow neurodegeneration and delay Alzheimer's disease?
    Brown BM; Peiffer JJ; Martins RN
    Mol Psychiatry; 2013 Aug; 18(8):864-74. PubMed ID: 23164816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise as a pro-cognitive, pro-neurogenic and anti-inflammatory intervention in transgenic mouse models of Alzheimer's disease.
    Ryan SM; Kelly ÁM
    Ageing Res Rev; 2016 May; 27():77-92. PubMed ID: 27039886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical exercise in the prevention and treatment of Alzheimer's disease.
    De la Rosa A; Olaso-Gonzalez G; Arc-Chagnaud C; Millan F; Salvador-Pascual A; García-Lucerga C; Blasco-Lafarga C; Garcia-Dominguez E; Carretero A; Correas AG; Viña J; Gomez-Cabrera MC
    J Sport Health Sci; 2020 Sep; 9(5):394-404. PubMed ID: 32780691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and Treatment of Alzheimer's Disease: Biological Mechanisms of Exercise.
    McGurran H; Glenn JM; Madero EN; Bott NT
    J Alzheimers Dis; 2019; 69(2):311-338. PubMed ID: 31104021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease.
    Batista AF; Forny-Germano L; Clarke JR; Lyra E Silva NM; Brito-Moreira J; Boehnke SE; Winterborn A; Coe BC; Lablans A; Vital JF; Marques SA; Martinez AM; Gralle M; Holscher C; Klein WL; Houzel JC; Ferreira ST; Munoz DP; De Felice FG
    J Pathol; 2018 May; 245(1):85-100. PubMed ID: 29435980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent fasting protects against the deterioration of cognitive function, energy metabolism and dyslipidemia in Alzheimer's disease-induced estrogen deficient rats.
    Shin BK; Kang S; Kim DS; Park S
    Exp Biol Med (Maywood); 2018 Feb; 243(4):334-343. PubMed ID: 29307281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's Disease: Physical Activities as an Effective Intervention Tool - A Mini-Review.
    Klimova B; Maresova P; Kuca K
    Curr Alzheimer Res; 2019; 16(2):166-171. PubMed ID: 30277151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of exercise interventions on cognitive outcome in Alzheimer's disease: a systematic review.
    Farina N; Rusted J; Tabet N
    Int Psychogeriatr; 2014 Jan; 26(1):9-18. PubMed ID: 23962667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical exercise reserved amyloid-beta induced brain dysfunctions by regulating hippocampal neurogenesis and inflammatory response via MAPK signaling.
    Sun LN; Qi JS; Gao R
    Brain Res; 2018 Oct; 1697():1-9. PubMed ID: 29729254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat therapy: possible benefits for cognitive function and the aging brain.
    Von Schulze AT; Deng F; Morris JK; Geiger PC
    J Appl Physiol (1985); 2020 Dec; 129(6):1468-1476. PubMed ID: 32969779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease.
    Bartzokis G
    Neurobiol Aging; 2004 Jan; 25(1):5-18; author reply 49-62. PubMed ID: 14675724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
    Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
    Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthy brain, healthy life: a review of diet and exercise interventions to promote brain health and reduce Alzheimer's disease risk.
    Baranowski BJ; Marko DM; Fenech RK; Yang AJT; MacPherson REK
    Appl Physiol Nutr Metab; 2020 Oct; 45(10):1055-1065. PubMed ID: 32717151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise for the diabetic brain: how physical training may help prevent dementia and Alzheimer's disease in T2DM patients.
    Bertram S; Brixius K; Brinkmann C
    Endocrine; 2016 Aug; 53(2):350-63. PubMed ID: 27160819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise counteracts declining hippocampal function in aging and Alzheimer's disease.
    Intlekofer KA; Cotman CW
    Neurobiol Dis; 2013 Sep; 57():47-55. PubMed ID: 22750524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease.
    Duarte AI; Santos MS; Oliveira CR; Moreira PI
    Neuropharmacology; 2018 Jul; 136(Pt B):223-242. PubMed ID: 29471055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug and Exercise Treatment of Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Effects on Cognition in Randomized Controlled Trials.
    Ströhle A; Schmidt DK; Schultz F; Fricke N; Staden T; Hellweg R; Priller J; Rapp MA; Rieckmann N
    Am J Geriatr Psychiatry; 2015 Dec; 23(12):1234-1249. PubMed ID: 26601726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of neuronal insulin/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer's disease: possible therapeutic implications.
    Zemva J; Schubert M
    CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):322-37. PubMed ID: 24059318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.